These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 17599052

  • 1. PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.
    Suzuki E, Imoto I, Pimkhaokham A, Nakagawa T, Kamata N, Kozaki KI, Amagasa T, Inazawa J.
    Oncogene; 2007 Dec 13; 26(57):7921-32. PubMed ID: 17599052
    [Abstract] [Full Text] [Related]

  • 2. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H, Imoto I, Tsuda H, Nakanishi Y, Ichikura T, Mochizuki H, Mitsufuji S, Hosoda F, Hirohashi S, Ohki M, Inazawa J.
    Oncogene; 2005 Dec 01; 24(54):8051-60. PubMed ID: 16103878
    [Abstract] [Full Text] [Related]

  • 3. Frequent silencing of a putative tumor suppressor gene melatonin receptor 1 A (MTNR1A) in oral squamous-cell carcinoma.
    Nakamura E, Kozaki K, Tsuda H, Suzuki E, Pimkhaokham A, Yamamoto G, Irie T, Tachikawa T, Amagasa T, Inazawa J, Imoto I.
    Cancer Sci; 2008 Jul 01; 99(7):1390-400. PubMed ID: 18452558
    [Abstract] [Full Text] [Related]

  • 4. Frequent silencing of low density lipoprotein receptor-related protein 1B (LRP1B) expression by genetic and epigenetic mechanisms in esophageal squamous cell carcinoma.
    Sonoda I, Imoto I, Inoue J, Shibata T, Shimada Y, Chin K, Imamura M, Amagasa T, Gray JW, Hirohashi S, Inazawa J.
    Cancer Res; 2004 Jun 01; 64(11):3741-7. PubMed ID: 15172977
    [Abstract] [Full Text] [Related]

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC, Yu Y.
    Cancer Res; 2003 Jul 15; 63(14):4174-80. PubMed ID: 12874023
    [Abstract] [Full Text] [Related]

  • 6. Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma.
    Uesugi H, Uzawa K, Kawasaki K, Shimada K, Moriya T, Tada A, Shiiba M, Tanzawa H.
    Int J Mol Med; 2005 Apr 15; 15(4):597-602. PubMed ID: 15754020
    [Abstract] [Full Text] [Related]

  • 7. Frequent silencing of protocadherin 17, a candidate tumour suppressor for esophageal squamous cell carcinoma.
    Haruki S, Imoto I, Kozaki K, Matsui T, Kawachi H, Komatsu S, Muramatsu T, Shimada Y, Kawano T, Inazawa J.
    Carcinogenesis; 2010 Jun 15; 31(6):1027-36. PubMed ID: 20200074
    [Abstract] [Full Text] [Related]

  • 8. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K, Imoto I, Inoue J, Kozaki K, Tsuda H, Shimada Y, Aiko S, Yoshizumi Y, Iwai T, Kawano T, Inazawa J.
    Oncogene; 2007 Sep 27; 26(44):6456-68. PubMed ID: 17438526
    [Abstract] [Full Text] [Related]

  • 9. Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis.
    Takada H, Imoto I, Tsuda H, Nakanishi Y, Sakakura C, Mitsufuji S, Hirohashi S, Inazawa J.
    Oncogene; 2006 Oct 19; 25(49):6554-62. PubMed ID: 16715143
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R, Tsuda H, Kozaki K, Kanai Y, Kasamatsu T, Sengoku K, Hirohashi S, Inazawa J, Imoto I.
    Cancer Res; 2008 Jul 01; 68(13):5067-75. PubMed ID: 18593905
    [Abstract] [Full Text] [Related]

  • 12. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 01; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 13. Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array.
    Nakaya K, Yamagata HD, Arita N, Nakashiro KI, Nose M, Miki T, Hamakawa H.
    Oncogene; 2007 Aug 09; 26(36):5300-8. PubMed ID: 17325662
    [Abstract] [Full Text] [Related]

  • 14. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH, Tan LK, Loh KS, Lim CY, Srivastava G, Tsai ST, Tsao SW, Tao Q.
    Oncogene; 2004 Jun 10; 23(27):4793-806. PubMed ID: 15122337
    [Abstract] [Full Text] [Related]

  • 15. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.
    Hepatology; 2012 Nov 10; 56(5):1817-27. PubMed ID: 22689435
    [Abstract] [Full Text] [Related]

  • 16. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer.
    Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T.
    Cancer Genet Cytogenet; 2010 Feb 10; 197(1):16-24. PubMed ID: 20113832
    [Abstract] [Full Text] [Related]

  • 17. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
    Baba S, Hara A, Kato K, Long NK, Hatano Y, Kimura M, Okano Y, Yamada Y, Shibata T.
    Oncol Rep; 2009 Nov 10; 22(5):1173-9. PubMed ID: 19787237
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
    Uzawa K, Ono K, Suzuki H, Tanaka C, Yakushiji T, Yamamoto N, Yokoe H, Tanzawa H.
    Clin Cancer Res; 2002 Mar 10; 8(3):828-35. PubMed ID: 11895916
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic regulation of the X-linked tumour suppressors BEX1 and LDOC1 in oral squamous cell carcinoma.
    Lee CH, Wong TS, Chan JY, Lu SC, Lin P, Cheng AJ, Chen YJ, Chang JS, Hsiao SH, Leu YW, Li CI, Hsiao JR, Chang JY.
    J Pathol; 2013 Jul 10; 230(3):298-309. PubMed ID: 23362108
    [Abstract] [Full Text] [Related]

  • 20. Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas.
    Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K.
    Cancer Res; 1998 Aug 01; 58(15):3429-34. PubMed ID: 9699676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.